Dysregulation of adipokines in the serum of breast cancer patients – role in pathogenesis and potential clinical application (preliminary studies)

Read full text Summarise with VIRAT
Authors: Maria-Laura Morawiec, Dominika Wendlocha, Jacek Kabut, Aleksandra Mielczarek‐Palacz
Cited by: 0
References: 75

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Introduction: The pathogenesis and diagnosis of breast cancer remain the subject of intensive research, as many aspects of these processes still require further elucidation. The dominant component of breast tissue stroma, adipose tissue, is composed of adipocytes, which secrete various cytokines, including adipokines, whose role in breast cancer is not fully understood. Methods: In this study, selected new adipokines were measured for the first time, including: progranulin (PGRN), follistatin-like protein 1 (FSTL1), asprosin (Asp), meteorin (METRN), adipsin (CFD), nesfatin (NES1), neuregulin 4 (NRG4), and isthmin (ISM1) in the serum of breast cancer patients, divided according to the molecular subtype and grade of the tumor. For the first time, the relationship between the adipokines studied and numerous standard laboratory parameters was also analyzed. Results: The study revealed a statistically significant difference in serum concentrations of adipsin and isthmin in breast cancer patients compared to the reference group, which may indicate systemic immune and inflammatory response disorders involving the studied adipokines. Discussion: The correlations between the studied adipokines in the course of breast cancer indicate their multifaceted effects on the pathogenesis of breast cancer, which requires further detailed research.

Fields of Study & Subjects

Adipokines Inflammation and Metabolic Diseases Cancer Risks and Factors Adipose Tissue and Metabolism

Publication details

Journal / source
Frontiers in Immunology
Volume
17
Pages
1724900–1724900
Publication date
31 March 2026
Language
EN